Matthew Garoufalis
Chief Medical Officer of Advanced Oxygen Therapy Inc. (AOTI), Dr. Matthew Garoufalis is a Co-Chair of the Alliance of Wound Care Stakeholders and past President of both the American Podiatric Medical Association and the International Federation of Podiatrists. He is recognized as a Key Opinion Leader on the diabetic foot, lower extremity wound care, limb salvage, podiatric medicine, and surgery. He earned his DPM from the Dr. William M. Scholl College of Podiatric Medicine in Chicago and completed a surgical residency at the Westside VA Medical Center in Chicago. He is Board Certified by the American Board of Foot and Ankle Surgery and American Board of Podiatric Medicine and is a Fellow of the American Society of Podiatric Surgeons and the American College of Foot and Ankle Orthopedics and Medicine. He is also a Certified Wound Specialist by the American Board of Wound Management. He has authored many articles and has lectured extensively on a variety of topics pertinent to wound care, podiatric medicine and su
David Armstrong
David G. Armstrong, DPM, PhD, is an internationally recognized leader in the field of podiatric surgery, diabetic foot, limb preservation, tissue repair and wound healing. He is founder and co-director of the Southwestern Academic Limb Salvage Alliance (SALSA), a clinical and research collaborative.
As director of USC’s Center to Stream Healthcare in Place (C2SHIP), he is advancing the latest research in consumer wearables and other health technologies. In 2021, he received a USC Stevens Technology Commercialization Award for his method for treating chronic diabetic foot ulcers, just one of multiple patents he holds.
Dr. Armstrong is coeditor of the American Diabetes Association textbook, Clinical Care of the Diabetic Foot, now in its third edition. He is responsible for more than 100 books or book chapters, along with 600 peer-reviewed research papers in leading medical journals.
His achievements have garnered multiple honors, including the 2010 American Diabetes Association’s Roger E. Pecoraro Award for Lifetime Achievement in Diabetic Foot Care, the highest honor in the field.
Dr. Armstrong is founding president of the American Limb Preservation Society (ALPS), which is bringing together clinicians to help eliminate preventable amputations in the United States and worldwide. He and his Keck Medicine of USC team are working to achieve that goal for people with diabetes over the next generation.
Chris Broderick
Prashant Tiwari
John Thompson
John is an international technology executive with over 35 years of experience in the fields of data, advanced analytics and artificial intelligence (AI).
John has been responsible for the global advanced analytics and AI function at a leading biopharmaceutical company where he led a team that developed and deployed over 25 analytical applications in 3 years. John was an Executive Partner at Gartner, where he was management consultant to market leading companies in the areas of digital transformation, data monetization and advanced analytics. Before Gartner, John was responsible for the advanced analytics business unit of the Dell Software Group.
John is the author of the best-selling book – Analytics Teams: Leveraging analytics and artificial intelligence for business improvement. The book was published in June 2020 and outlines how to hire and manage high performance advanced analytics teams. The book outlines how to engage with executives and senior managers. How to select and undertake analytics projects that change and improve how a business operates.
John is co-author of the bestselling book – Analytics: How to win with Intelligence, which debuted on Amazon as the #1 new book in Analytics in 2017. Analytics is a book that guides non-technical executives through the journey of creating an analytics function, funding initiatives, and driving change in business operations through data and applied analytical applications.
John’s new book – The Future of Data, will be published in 2022.
Xiaoyong Liu
Robert Crousore
Robert has 28 years of experience in the health care products and
services industry. Crousore is a serial entrepreneur with multiple
successful product and services company exits. His experience spans
the entire business enterprise including Sales, Marketing, Operations,
Product Innovation and, most recently M & A.
Highlights Include:
- Has successfully managed a global commercial organization in the wound care business.
- Has a number of patent credits for products in the wound care industry.
- Sits on multiple boards of healthcare technology companies.
- His passion is creating meaningful changes in patient care by combining great products with great teams that are focused on empowering improved clinical and financial outcomes.
Thomas Busby
Thomas Busby is a Vice President and has been with Outcome Capital since 2015. He focuses on medical technology, digital health and life science services segments with particular interest in innovative life science companies that deliver patient impact by leveraging novel approaches. Thomas is driven by the desire to identify disruptive technologies and services that require unique strategic thought and assistance to realize their full market potential. Thomas has been published in leading life science journals Life Science Leader and The Pharma Letter, and also serves on the board of HealthTech Build, a Boston-based digital health innovation group.
Prior to his career in life-science investment banking, Thomas pursued his passion for the public service and non-profit sectors working in a variety of leadership and management positions, and at one time held a Massachusetts teaching license.
Thomas completed his MBA at Suffolk University’s Sawyer Business School on full academic scholarship where he was President of the school’s Graduate Business Association and class speaker at graduation. Prior, he completed a BS in Philosophy with Honors from Suffolk’s College of Arts & Sciences. Committed to giving back, Thomas is currently the President of the College of Arts & Sciences Alumni Board of Directors. Thomas is a FINRA Registered Securities Representative holding his Series 79 and 63.